Maciej Kołodziej

20PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyToxicology (incl. clinical toxicology)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 03, 2026
Long-term toxicity of tandem radioligand therapy using [90Y]Y/[177Lu]Lu-DOTA-TATE in neuroendocrine tumors: a polish multicenter experience with 20-year follow-up.

|Oct 16, 2025
Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors.

Katarzyna Jóźwik-Plebanek, Marek Saracyn, Maciej Kołodziej

|Oct 16, 2025
Comparison of Localization Methods in Cushing Disease-Could [11C]C-Methionine PET/CT Replace MRI or BIPSS?

Adam Daniel Durma, Marek Saracyn, Maciej Kołodziej

|Oct 02, 2025
The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

Maciej Kołodziej, Violetta Rosiek, Jan Musiałkiewicz

|Sep 02, 2025
Clinicopathological insights into primary hyperparathyroidism: a comprehensive single-center retrospective study.

Dorota Anna Brodowska-Kania, Marek Saracyn, Natalia Osial

|Mar 19, 2025
Carcinoid crisis induced by radioligand therapy: a rare but life-threatening complication in patient with neuroendocrine tumor.

Dorota Anna Brodowska-Kania, Marek Saracyn, Natalia Osial

Pageof 4

Frequent Collaborators

16 joint publications

Grzegorz Kamiński

14 joint publications

Adam Daniel Durma

9 joint publications

Katarzyna Jóźwik-Plebanek

9 joint publications

Marek Saracyn